熱門資訊> 正文
大多数医疗保险D部分参与者将在2027年看到更高的保费
2026-07-29 07:00
- A Trump administration decision to end a Medicare Part D subsidy program means that three out of four enrollees will see higher plan premiums in 2027.
- About 45% of enrollees will see a $11-$20 monthly increase, while another 30% will pay $10 or under more per month, according to a report in The Wall Street Journal.
- An administration official told the newspaper that the subsidy provided an incentive for health insurers to boost rates as the federal government would foot the additional amount.
- The subsidy provided ~$3.6B in support in 2026, according to the Government Accountability Office.
- The top Medicare Part D insurers include Centene (CNC), Humana (HUM), and UnitedHealth Group (UNH).
More on Centene, Humana
- Centene Corporation (CNC) Q2 2026 Earnings Call Transcript
- Humana: Q2 Earnings Must Catch Up With The Stock
- Centene Proved Bears Wrong
- Centene forecasts 2026 adjusted EPS greater than $4.80 as Marketplace pretax margin targets 4.5%-5%
- Humana Q2 2026 Earnings Preview
推薦文章
港股周報 | 黃金股狂飆！靈寶黃金周升24%；段永平「被動減持」泡泡瑪特；藥明康德升近20%創新高
一周財經日曆 | 重磅財報周！騰訊、Lumentum、中芯國際輪番登場！美國7月CPI攜零售數據來襲
8月8日外盤頭條：伊朗內部辯論霍爾木茲協議措辭 非農爆冷削弱加息預期 SpaceX將自建發電廠保障電力供應
Palantir股價將創下自2024年以來最佳單周表現，該股已不再是AI領域的失意者
7月非農就業數據走弱，支持美聯儲維持利率不變，但加息選項並未徹底排除
美股前瞻 | 聚焦20：30！市場靜候7月非農數據；特朗普政府擬加碼佈局關鍵礦產；應用光電計劃大規模擴產，光通信盤前集體飆升
港股異動 | 創新葯概念再度走強，再鼎新葯勁升14%，Q2產品收入環比增長11%；藥明生物升逾5%，百濟神州升逾3%
港股異動 | AI硬件股多數上漲，建滔積層板、勝宏科技漲逾5%，兆易創新漲逾3%；南方兩倍做多海力士跌逾9%
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
